| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoclasts | 37 | 2021 | 132 | 7.340 |
Why?
|
| RANK Ligand | 22 | 2020 | 73 | 5.130 |
Why?
|
| Osteitis Deformans | 16 | 2017 | 19 | 3.670 |
Why?
|
| Bone Resorption | 16 | 2021 | 64 | 2.810 |
Why?
|
| Cell Differentiation | 20 | 2021 | 1034 | 2.630 |
Why?
|
| Osteogenesis | 6 | 2021 | 152 | 2.270 |
Why?
|
| Weightlessness | 5 | 2019 | 25 | 2.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2011 | 214 | 2.020 |
Why?
|
| Transcription Factors | 13 | 2014 | 753 | 1.950 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 4 | 2019 | 65 | 1.810 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2019 | 629 | 1.690 |
Why?
|
| Mouth Neoplasms | 5 | 2019 | 206 | 1.640 |
Why?
|
| Gene Expression Regulation | 12 | 2021 | 1293 | 1.470 |
Why?
|
| Osteoblasts | 6 | 2014 | 99 | 1.410 |
Why?
|
| Heat-Shock Proteins | 6 | 2011 | 69 | 1.100 |
Why?
|
| Proteasome Endopeptidase Complex | 7 | 2019 | 69 | 1.090 |
Why?
|
| Bone Marrow Cells | 12 | 2019 | 217 | 1.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 7 | 2019 | 17 | 1.030 |
Why?
|
| Membrane Proteins | 2 | 2021 | 617 | 0.990 |
Why?
|
| Fibroblast Growth Factor 2 | 5 | 2013 | 48 | 0.980 |
Why?
|
| Mice | 28 | 2021 | 8474 | 0.940 |
Why?
|
| Stromal Cells | 8 | 2014 | 113 | 0.940 |
Why?
|
| NFATC Transcription Factors | 9 | 2021 | 40 | 0.830 |
Why?
|
| Signal Transduction | 17 | 2020 | 2689 | 0.810 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2021 | 17 | 0.780 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2021 | 33 | 0.780 |
Why?
|
| Blotting, Western | 11 | 2017 | 954 | 0.720 |
Why?
|
| Nucleocapsid Proteins | 6 | 2017 | 8 | 0.710 |
Why?
|
| Chemokine CXCL13 | 2 | 2010 | 8 | 0.710 |
Why?
|
| Calcitriol | 7 | 2014 | 106 | 0.700 |
Why?
|
| Animals | 31 | 2021 | 20881 | 0.700 |
Why?
|
| Leupeptins | 1 | 2019 | 23 | 0.690 |
Why?
|
| Autophagy | 3 | 2018 | 208 | 0.670 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2019 | 73 | 0.660 |
Why?
|
| RAW 264.7 Cells | 5 | 2020 | 42 | 0.650 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 15 | 0.620 |
Why?
|
| Cells, Cultured | 13 | 2017 | 2673 | 0.610 |
Why?
|
| Cell Line | 13 | 2020 | 1752 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 756 | 0.590 |
Why?
|
| Transcriptional Activation | 3 | 2016 | 226 | 0.570 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2014 | 710 | 0.560 |
Why?
|
| Homeostasis | 1 | 2018 | 291 | 0.550 |
Why?
|
| Promoter Regions, Genetic | 9 | 2014 | 615 | 0.520 |
Why?
|
| Membrane Glycoproteins | 4 | 2006 | 370 | 0.520 |
Why?
|
| Carrier Proteins | 4 | 2006 | 597 | 0.490 |
Why?
|
| STAT6 Transcription Factor | 1 | 2014 | 11 | 0.490 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 282 | 0.480 |
Why?
|
| Bone Marrow | 3 | 2019 | 168 | 0.480 |
Why?
|
| Proteins | 5 | 2006 | 474 | 0.470 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 8 | 0.470 |
Why?
|
| Phosphorylation | 5 | 2021 | 1200 | 0.470 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 12 | 0.450 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 1851 | 0.450 |
Why?
|
| Bone Remodeling | 3 | 2009 | 45 | 0.440 |
Why?
|
| Chemokine CXCL5 | 1 | 2013 | 3 | 0.440 |
Why?
|
| Bone and Bones | 3 | 2018 | 145 | 0.440 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 6 | 2010 | 14 | 0.430 |
Why?
|
| LIM Domain Proteins | 6 | 2010 | 15 | 0.430 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 498 | 0.430 |
Why?
|
| TNF Receptor-Associated Factor 6 | 4 | 2019 | 14 | 0.420 |
Why?
|
| Sequestosome-1 Protein | 5 | 2019 | 12 | 0.420 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2008 | 6 | 0.370 |
Why?
|
| Osteolysis | 1 | 2010 | 15 | 0.360 |
Why?
|
| Fractures, Bone | 2 | 2010 | 132 | 0.360 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 226 | 0.350 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2009 | 2 | 0.350 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 434 | 0.350 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2009 | 4 | 0.340 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2010 | 160 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 2791 | 0.340 |
Why?
|
| Receptors, IgG | 1 | 2010 | 94 | 0.340 |
Why?
|
| Humans | 33 | 2020 | 68618 | 0.340 |
Why?
|
| Interleukin-12 | 1 | 2009 | 75 | 0.320 |
Why?
|
| Tibia | 1 | 2009 | 93 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2020 | 114 | 0.320 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 41 | 0.320 |
Why?
|
| Measles virus | 4 | 2013 | 7 | 0.310 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2007 | 4 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.290 |
Why?
|
| Eye Proteins | 1 | 2008 | 160 | 0.280 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2014 | 140 | 0.280 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 209 | 0.280 |
Why?
|
| Kininogens | 1 | 2006 | 88 | 0.270 |
Why?
|
| Response Elements | 1 | 2005 | 29 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2014 | 71 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 290 | 0.260 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 215 | 0.260 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2020 | 77 | 0.250 |
Why?
|
| Antigen Presentation | 2 | 2020 | 76 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 216 | 0.240 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 1174 | 0.240 |
Why?
|
| Microscopy, Confocal | 4 | 2014 | 337 | 0.230 |
Why?
|
| Receptors, Calcitriol | 3 | 2014 | 49 | 0.230 |
Why?
|
| Space Flight | 2 | 2018 | 40 | 0.230 |
Why?
|
| Base Sequence | 6 | 2006 | 1015 | 0.230 |
Why?
|
| HSP27 Heat-Shock Proteins | 3 | 2009 | 10 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1174 | 0.220 |
Why?
|
| RNA, Messenger | 6 | 2017 | 1664 | 0.220 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.220 |
Why?
|
| Macrophages | 3 | 2020 | 647 | 0.210 |
Why?
|
| Mice, Transgenic | 7 | 2010 | 1033 | 0.210 |
Why?
|
| Vitamin D | 4 | 2017 | 516 | 0.200 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.200 |
Why?
|
| Gene Expression | 4 | 2009 | 770 | 0.190 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 1447 | 0.190 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 58 | 0.180 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2020 | 46 | 0.180 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 38 | 0.180 |
Why?
|
| Kynurenine | 1 | 2020 | 36 | 0.180 |
Why?
|
| STAT1 Transcription Factor | 2 | 2013 | 35 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 492 | 0.180 |
Why?
|
| Apoptosis | 3 | 2018 | 1641 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2019 | 447 | 0.170 |
Why?
|
| Stem Cells | 2 | 2014 | 248 | 0.170 |
Why?
|
| Janus Kinases | 1 | 2019 | 11 | 0.170 |
Why?
|
| Osteoprotegerin | 2 | 2018 | 11 | 0.170 |
Why?
|
| Acid Ceramidase | 1 | 2020 | 85 | 0.170 |
Why?
|
| Caspase 1 | 1 | 2019 | 22 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 61 | 0.170 |
Why?
|
| Ubiquitination | 1 | 2019 | 85 | 0.170 |
Why?
|
| Podosomes | 1 | 2019 | 1 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 186 | 0.160 |
Why?
|
| Mutation | 3 | 2011 | 1213 | 0.160 |
Why?
|
| Lysosomes | 1 | 2019 | 136 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 320 | 0.160 |
Why?
|
| Cytokines | 1 | 2003 | 866 | 0.160 |
Why?
|
| Cell Death | 1 | 2019 | 329 | 0.160 |
Why?
|
| Triterpenes | 1 | 2018 | 40 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2019 | 682 | 0.150 |
Why?
|
| Chemokines | 1 | 2019 | 119 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 99 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2014 | 1692 | 0.150 |
Why?
|
| Genes, Reporter | 3 | 2008 | 191 | 0.150 |
Why?
|
| Transfection | 3 | 2010 | 782 | 0.150 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 33 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 271 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2010 | 2550 | 0.140 |
Why?
|
| Interferon-gamma | 2 | 2009 | 241 | 0.140 |
Why?
|
| DNA Primers | 3 | 2006 | 302 | 0.130 |
Why?
|
| Luciferases | 2 | 2008 | 105 | 0.130 |
Why?
|
| Microarray Analysis | 1 | 2016 | 63 | 0.130 |
Why?
|
| Annexin A2 | 2 | 2006 | 3 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1070 | 0.130 |
Why?
|
| Anthracenes | 2 | 2014 | 26 | 0.130 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 1083 | 0.130 |
Why?
|
| Models, Biological | 2 | 2010 | 981 | 0.130 |
Why?
|
| Milk, Human | 1 | 2017 | 147 | 0.130 |
Why?
|
| Paramyxoviridae Infections | 2 | 2006 | 3 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 175 | 0.130 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 132 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2017 | 431 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 60 | 0.120 |
Why?
|
| Protein Binding | 2 | 2010 | 1027 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 57 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 114 | 0.120 |
Why?
|
| Weightlessness Simulation | 1 | 2014 | 6 | 0.120 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 53 | 0.120 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2013 | 4 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 12 | 0.110 |
Why?
|
| CREB-Binding Protein | 1 | 2013 | 10 | 0.110 |
Why?
|
| Vitamins | 1 | 2014 | 134 | 0.110 |
Why?
|
| Calcium | 1 | 2017 | 929 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2005 | 250 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 432 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 778 | 0.100 |
Why?
|
| Cell Survival | 3 | 2018 | 901 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 81 | 0.090 |
Why?
|
| Syk Kinase | 1 | 2010 | 10 | 0.090 |
Why?
|
| Astronauts | 1 | 2010 | 20 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2010 | 38 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 195 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2010 | 294 | 0.080 |
Why?
|
| RNA Interference | 1 | 2010 | 266 | 0.080 |
Why?
|
| Jurkat Cells | 1 | 2009 | 59 | 0.080 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 204 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 86 | 0.080 |
Why?
|
| Bone Density | 1 | 2009 | 159 | 0.080 |
Why?
|
| Models, Animal | 1 | 2009 | 252 | 0.080 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2008 | 20 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2009 | 202 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 82 | 0.080 |
Why?
|
| SMN Complex Proteins | 1 | 2007 | 1 | 0.080 |
Why?
|
| Transcription Factor TFIID | 2 | 2004 | 4 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 124 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 333 | 0.070 |
Why?
|
| Bone Development | 1 | 2007 | 37 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 357 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 301 | 0.070 |
Why?
|
| Peptides | 2 | 2007 | 455 | 0.070 |
Why?
|
| Etoposide | 1 | 2006 | 64 | 0.070 |
Why?
|
| Receptors, Peptide | 1 | 2006 | 32 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 30 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 71 | 0.070 |
Why?
|
| Vidarabine | 1 | 2005 | 12 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 81 | 0.070 |
Why?
|
| Genes, Viral | 1 | 2005 | 44 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2006 | 90 | 0.070 |
Why?
|
| Mice, Inbred DBA | 2 | 2020 | 120 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 328 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 742 | 0.060 |
Why?
|
| Melanoma | 1 | 2008 | 335 | 0.060 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2003 | 3 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 307 | 0.060 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 37 | 0.060 |
Why?
|
| Biomarkers | 1 | 2009 | 1593 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 375 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 4848 | 0.060 |
Why?
|
| Integrins | 1 | 2004 | 115 | 0.060 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2004 | 324 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2003 | 305 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2002 | 19 | 0.050 |
Why?
|
| Peptide Mapping | 1 | 2002 | 39 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 78 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2002 | 89 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 93 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 251 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 322 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2020 | 22 | 0.050 |
Why?
|
| HLA-DR4 Antigen | 1 | 2020 | 11 | 0.050 |
Why?
|
| Cathepsins | 1 | 2020 | 37 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
| Monocytes | 3 | 2006 | 210 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 2324 | 0.040 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 37 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2018 | 85 | 0.040 |
Why?
|
| Aged | 2 | 2013 | 14862 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 329 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 174 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2018 | 233 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2019 | 190 | 0.040 |
Why?
|
| Calpain | 1 | 2018 | 205 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 231 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 261 | 0.040 |
Why?
|
| Child | 1 | 2007 | 6405 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 4655 | 0.030 |
Why?
|
| Middle Aged | 1 | 2013 | 21147 | 0.030 |
Why?
|
| Sp7 Transcription Factor | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 292 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 160 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 164 | 0.030 |
Why?
|
| Male | 2 | 2018 | 37321 | 0.020 |
Why?
|
| Female | 2 | 2017 | 38074 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2008 | 50 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 507 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2006 | 22 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 36 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 489 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 65 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 397 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2006 | 80 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5717 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 173 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 541 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2006 | 308 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 32 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2004 | 19 | 0.020 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2004 | 24 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 62 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 101 | 0.020 |
Why?
|
| Kinetics | 1 | 2006 | 1047 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 66 | 0.020 |
Why?
|
| Flavonoids | 1 | 2005 | 109 | 0.010 |
Why?
|
| Nucleoproteins | 1 | 2004 | 6 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2004 | 9 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 155 | 0.010 |
Why?
|
| Viral Core Proteins | 1 | 2004 | 12 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 16 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 330 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 626 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2004 | 62 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 146 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 137 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 238 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 396 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 786 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2005 | 331 | 0.010 |
Why?
|
| Sequence Analysis, RNA | 1 | 2002 | 34 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 231 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 21403 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1553 | 0.010 |
Why?
|